Cell Line‐based Assessment of BTK Inhibitors

British Journal of Pharmacology - United States
doi 10.1111/bph.14948
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Flow Cytometry Assessment of Intracellular BTK Expression

Cytometry Part B - Clinical Cytometry
Forensic MedicinePathologyHistologyCell Biology
2017English

Differential Effects of BTK Inhibitors Ibrutinib and Zanubrutinib on NK Cell Effector Function in Patients With Mantle Cell Lymphoma

Haematologica
Hematology
2019English

Second Cancer Incidence in CLL Patients Receiving BTK Inhibitors

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Correction of B-Cell Development in BTK-Deficient Mice Using Lentiviral Vectors With Codon-Optimized Human BTK

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2010English

Online Education Significantly Improved the Competence of Hematologists/Oncologists and Nurses Regarding the Use of BTK Inhibitors for Mantle Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Identification and Evaluation of Coronavirus Replicase Inhibitors Using a Replicon Cell Line

Advances in Experimental Medicine and Biology
BiochemistryMedicineGeneticsMolecular Biology
2006English

BTK Inhibitor Ibrutinib in CLL and Mantle Cell Lymphoma

Community Oncology
2013English

Activity of EGFR, mTOR and PI3K Inhibitors in an Isogenic Breast Cell Line Model

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2014English

Assessment of Combined Scale/Corrosion Inhibitors – A Combined Jar Test/Bubble Cell

Journal of Petroleum Science and Engineering
Geotechnical EngineeringFuel TechnologyEngineering Geology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy